Effectiveness of deferred therapy with ganciclovir in renal allograft recipients with cytomegalovirus disease

被引：7
|
作者：
Waiser, J
Budde, K
Schreiber, M
Korn, K
Stenglein, S
Drenckhahn, JT
Böhler, T
Hauser, I
Neumayer, HH
机构：
[1] Humboldt Univ, Dept Internal Med Nephrol, Berlin, Germany
[2] Univ Erlangen Nurnberg, Dept Internal Med Nephrol, D-8520 Erlangen, Germany
[3] Univ Erlangen Nurnberg, Inst Clin & Mol Virol, D-8520 Erlangen, Germany
来源：
TRANSPLANTATION PROCEEDINGS | 1998年 / 30卷 / 05期
关键词：
D O I：
10.1016/S0041-1345(98)00547-8
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2083 / 2085
页数：3
相关论文
共 50 条
  • [1] Prophylactic oral ganciclovir compared with deferred therapy for control of cytomegalovirus in renal transplant recipients
    Brennan, DC
    Garlock, KA
    Singer, GG
    Schnitzler, MA
    Lippmann, BJ
    Buller, RS
    Gaudreault-Keener, M
    Lowell, JA
    Shenoy, S
    Howard, TK
    Storch, GA
    TRANSPLANTATION, 1997, 64 (12) : 1843 - 1846
  • [2] GANCICLOVIR FOR INVASIVE CYTOMEGALOVIRUS-INFECTION IN RENAL-ALLOGRAFT RECIPIENTS
    HREBINKO, R
    JORDAN, ML
    DUMMER, JS
    HICKEY, DP
    SHAPIRO, R
    VIVAS, C
    STARZL, TE
    SIMMONS, RL
    HAKALA, TR
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (01) : 1346 - 1347
  • [3] Valacyclovir for cytomegalovirus prophylaxis reduces the risk of acute renal allograft rejection: A randomized comparison with oral ganciclovir and deferred therapy
    Reischig, T
    Jindra, P
    Mares, J
    Opatrny, K
    Treska, V
    Cechura, M
    Svecova, M
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 493 - 493
  • [4] Treatment of active cytomegalovirus disease with oral ganciclovir in renal allograft recipients: Monitoring efficacy with quantitative cytomegalovirus polymerase chain reaction
    Jordan, SC
    Vo, A
    Bunnapradist, S
    Toyoda, M
    Kamil, E
    AMERICAN JOURNAL OF TRANSPLANTATION, 2002, 2 (07) : 671 - 673
  • [5] GANCICLOVIR PROPHYLAXIS FOR CYTOMEGALOVIRUS INFECTIONS IN PULMONARY ALLOGRAFT RECIPIENTS
    DUNCAN, SR
    PARADIS, IL
    DAUBER, JH
    YOUSEM, SA
    HARDESTY, RL
    GRIFFITH, BP
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 146 (05): : 1213 - 1215
  • [6] GANCICLOVIR THERAPY FOR CYTOMEGALOVIRUS DISEASE IN LIVER-TRANSPLANT RECIPIENTS
    SHAEFER, MS
    STRATTA, RJ
    MARKIN, RS
    CUSHING, KA
    WOODS, GL
    REED, EC
    WOOD, RP
    LANGNAS, AN
    SHAW, BW
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (01) : 1515 - 1516
  • [7] PREVENTION OF CYTOMEGALOVIRUS DISEASE IN RENAL-ALLOGRAFT RECIPIENTS
    BALFOUR, HH
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1991, : 88 - 93
  • [8] THERAPEUTIC USE OF GANCICLOVIR FOR INVASIVE CYTOMEGALOVIRUS-INFECTION IN CADAVERIC RENAL-ALLOGRAFT RECIPIENTS
    JORDAN, ML
    HREBINKO, RL
    DUMMER, JS
    HICKEY, DP
    SHAPIRO, R
    VIVAS, CA
    SIMMONS, RL
    STARZL, TE
    HAKALA, TR
    JOURNAL OF UROLOGY, 1992, 148 (05): : 1388 - 1392
  • [9] GANCICLOVIR THERAPY OF SYMPTOMATIC CYTOMEGALOVIRUS-INFECTION IN RENAL-TRANSPLANT RECIPIENTS
    GUERIN, C
    POZZETTO, B
    BROYET, C
    GAUDIN, O
    BERTHOUX, F
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1989, 4 (10) : 906 - 910
  • [10] PREEMPTIVE GANCICLOVIR THERAPY IN CYTOMEGALOVIRUS-SEROPOSITIVE RENAL-TRANSPLANTS RECIPIENTS
    CONTI, DJ
    FREED, BM
    SINGH, TP
    GALLICHIO, M
    GRUBER, SA
    LEMPERT, N
    ARCHIVES OF SURGERY, 1995, 130 (11) : 1217 - 1222
12345